1877.HK - Shanghai Junshi Biosciences Co., Ltd.

HKSE - HKSE Delayed price. Currency in HKD
Currency in HKD

Valuation measures4

Market cap (intra-day) 50.31B
Enterprise value 45.02B
Trailing P/E N/A
Forward P/E 588.24
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.73
Price/book (mrq)2.58
Enterprise value/revenue 30.97
Enterprise value/EBITDA -19.14

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-42.92%
S&P500 52-week change 31.77%
52-week high 350.150
52-week low 321.200
50-day moving average 329.118
200-day moving average 331.552

Share statistics

Avg vol (3-month) 3956.27k
Avg vol (10-day) 3765.33k
Shares outstanding 5219.3M
Implied shares outstanding 6N/A
Float 8607.45M
% held by insiders 122.84%
% held by institutions 131.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin -234.92%
Operating margin (ttm)-280.60%

Management effectiveness

Return on assets (ttm)-16.40%
Return on equity (ttm)-31.89%

Income statement

Revenue (ttm)1.08B
Revenue per share (ttm)1.15
Quarterly revenue growth (yoy)-59.50%
Gross profit (ttm)1.45B
EBITDA -2.8B
Net income avi to common (ttm)-2.54B
Diluted EPS (ttm)-2.840
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.42B
Total cash per share (mrq)5.49
Total debt (mrq)1.39B
Total debt/equity (mrq)15.01
Current ratio (mrq)3.87
Book value per share (mrq)9.08

Cash flow statement

Operating cash flow (ttm)-3.07B
Levered free cash flow (ttm)-2.43B